Search

Vericel Corp

Fechado

SetorSaúde

43.17 2.57

Visão Geral

Variação de preço das ações

24h

Atual

Mín

42.09

Máximo

43.2

Indicadores-chave

By Trading Economics

Rendimento

13M

6.3M

Vendas

9M

77M

P/E

Médio do Setor

88.125

57.366

EPS

0.04

Margem de lucro

8.136

Funcionários

398

EBITDA

8.5M

5.6M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+48.16% upside

Dividendos

By Acuity

Próximos Ganhos

5 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-148M

2.2B

Abertura anterior

40.6

Fecho anterior

43.17

Sentimento de Notícias

By Acuity

100%

0%

329 / 340 Ranking em Healthcare

Vericel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

20 de ago. de 2026, 20:02 UTC

Correlated Moves

Vericel Corp shares are declining amid broader market pressures, reflecting negative sentiment from disappointing sales growth and guidance from Walmart Inc.

19 de ago. de 2026, 23:26 UTC

Vericel Corp shares are lower in after-market trading, reflecting ongoing weakness. The stock remains near the lower end of its one-month range.

18 de ago. de 2026, 19:26 UTC

Vericel Corp shares are higher today, reflecting positive market sentiment despite no specific news. The stock remains up since Monday's close.

13 de ago. de 2026, 19:43 UTC

Vericel Corp shares are lower today, reflecting ongoing weakness below the 20-day moving average and near the lower end of their one-month range.

11 de ago. de 2026, 19:46 UTC

News

Vericel Corp shares are higher as analysts maintain a "Moderate Buy" consensus, with HC Wainwright's target at $70 and Truist raising its target to $58.

10 de ago. de 2026, 19:46 UTC

Correlated Moves

Vericel Corp shares are lower today, reflecting a broader market decline and volatility amid uncertainty over the Federal Reserve's interest rate policy.

7 de ago. de 2026, 19:16 UTC

Correlated Moves

Vericel Corp's shares rise, supported by gains in the ARK Genomic Revolution ETF and Russell 2000 Index, despite earlier fluctuations in trading.

6 de ago. de 2026, 19:26 UTC

Correlated Moves

Vericel Corp shares declined during Thursday's session, tracking broader market trends. The stock remains near the lower end of its one-month trading range.

5 de ago. de 2026, 19:26 UTC

Correlated Moves

Vericel Corp shares are lower today, reflecting broader market trends as the Russell 2000 Index declines. The stock remains below its 20-day moving average.

3 de ago. de 2026, 20:03 UTC

Correlated Moves

Vericel Corp shares are advancing, supported by significant gains in the broader market and major tech stocks, contributing to positive investor sentiment.

31 de jul. de 2026, 20:02 UTC

Correlated Moves

Vericel Corp's price is lower today, influenced by declines in the Biotechnology sub-sector and a falling Russell 2000 Index.

30 de jul. de 2026, 20:36 UTC

Correlated Moves

Vericel Corp shares gained in after-market trading, aligning with a rising Russell 2000 Index. The stock remains above its 20-day moving average.

29 de jul. de 2026, 19:27 UTC

Correlated Moves

Vericel Corp shares declined during Wednesday's session, continuing a downward trend since Tuesday's close, amid broader market weakness reflected in the Russell 2000 Index.

28 de jul. de 2026, 21:02 UTC

Vericel Corp shares are lower in after-market trading, reflecting broader market caution amid declines in the Nikkei 225 Index and technology sector concerns.

27 de jul. de 2026, 20:31 UTC

Vericel Corp shares declined during after-market hours amid unusual selling pressure. The stock remains below its 20-day moving average with no specific news identified.

24 de jul. de 2026, 19:46 UTC

Correlated Moves

Vericel Corp reported first-quarter revenue of $39.2 million, missing estimates. Shares are lower amid broader market declines affecting small-cap biotechnology stocks.

22 de jul. de 2026, 20:13 UTC

Vericel Corp shares are trading higher in after-market hours, influenced by broader market volatility amid rising crude oil prices and geopolitical tensions.

21 de jul. de 2026, 14:31 UTC

Vericel Corp shares are higher, supported by overall market momentum and a recovery in Asian markets, particularly the Nikkei 225 Index.

20 de jul. de 2026, 17:46 UTC

Correlated Moves

Vericel Corp shares are lower today, aligning with a decline in the ARK Genomic Revolution ETF and the Russell 2000 Index.

Comparação entre Pares

Variação de preço

Vericel Corp Previsão

Preço-alvo

By TipRanks

48.16% parte superior

Previsão para 12 meses

Média 62.67 USD  48.16%

Máximo 72 USD

Mínimo 58 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Vericel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

4

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Vericel Corp

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
help-icon Live chat